Takeda Oncology Company Recruits Director, HR Business Partner

GattiHR Assists Takeda Oncology Company in Recruiting Key Member of Their Leadership Team

Image result for takeda oncology company

GattiHR is pleased to announce Jim O’Bryan has joined Takeda Oncology Company as Director, HR Business Partner.

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. Innovative products, especially in oncology and gastroenterology, as well as Takeda’s presence in emerging markets, are currently fueling the growth of Takeda. Approximately 30,000 Takeda employees are committed to improving quality of life for patients, working with Takeda’s partners in health care in more than 70 countries. (www.TakedaOncology.com).

Jim was most recently Director of Human Resources at Kite Pharma, Inc.

“Jim is an excellent addition to Takeda Oncology, “said Kevin Coughlin, Managing Director at GattiHR.. “His vision for the organization’s growth and thought leadership make her a great asset.”